Category: Biotechnology
Global Biotechnology
-
Microarray Analysis
... CAGR of 6.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
microRNA (miRNA)
... CAGR of 13.1% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$411.8 Million by the end of the analysis period. ... Read More
-
Oligonucleotide Synthesis
... CAGR of 15.6% over the analysis period 2024-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Cloning, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
Dairy Enzymes
... CAGR of 6.8% over the analysis period 2024-2030. Chymosin, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$442.0 Million by the end of the analysis period. ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by ... Read More
-
Exosomes
... 14.6% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$921.6 Million by the end of the analysis period. Growth in ... Read More
-
Food Ultrasound
... CAGR of 4.5% over the analysis period 2024-2030. High-intensity, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$96.5 Million by the end of the analysis period. ... Read More
-
Gel Permeation Chromatography Systems
... 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Pharma & Biotech Companies, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.4 Billion ... Read More
-
GMO Testing
... CAGR of 7.0% over the analysis period 2024-2030. Stacked, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.6 Billion by the end of the analysis period. ... Read More
-
Protein Purification and Isolation
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$10.3 Billion by the end ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Stem Cell Assays
... at a CAGR of 17.9% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by the end of the ... Read More
-
Stem Cell Services
... at a CAGR of 9.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market in the U.S. ... Read More
-
Terahertz Technology
... CAGR of 28.8% over the analysis period 2024-2030. Terahertz Source, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Bovine-Based Collagen for Biomedical Applications
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$526.9 ... Read More
-
Biopharmaceutical Fermentation Systems
... at a CAGR of 4.5% over the analysis period 2024-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Biotechnology
... 8.5% over the analysis period 2024-2030. DNA Sequencing Market, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis period. ... Read More
-
Chromatographic Silica Resins
... at a CAGR of 3.6% over the analysis period 2024-2030. Process Chromatography, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$63.8 Million by the end of ... Read More
-
Drug Discovery Technologies
... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More
-
Marine Biotechnology
... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More
-
Baking Enzymes
... CAGR of 5.0% over the analysis period 2024-2030. Carbohydrase, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$866.5 Million by the end of the analysis period. ... Read More
-
Cell Dissociation
... CAGR of 11.6% over the analysis period 2024-2030. Enzymatic Dissociation Products, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$506.9 Million by the end of the ... Read More
-
Gel Electrophoresis
... CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
Research Assistance
